Arbor Biotechnologies Competitors and Similar CompaniesClear all

Editas Medicine's competitors and similar companies include Sana Biotechnology, Nuclera and Caribou Biosciences.

	Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.	Sana Biotechnology Sana Biotechnology is a company specializing in cell and gene therapy.	Nuclera Nuclera is a company that specializes in DNA synthesis.	Caribou Biosciences Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company.
Founding Date	Founding Date 2013	Founding Date 2018	Founding Date 2013	Founding Date 2012
Type	Type Public	Type Public	Type Private	Type Public
Tags	Tags Healthcare bioengineering biotech genetics	Tags Healthcare bioengineering biotech genetics	Tags Healthcare bioengineering biotech genetics	Tags Healthcare bioengineering biotech genetics
Locations	Locations Cambridge, US HQ Boulder, US Cambridge, US	Locations Seattle, US HQ Cambridge, US South San Francisco, US	Locations Cambridge, GB HQ	Locations Berkeley, US HQ
Employees	Employees 20816% increase	Employees 19441% decrease	Employees 1192% decrease	Employees 1477% decrease
Valuation ($)	Valuation ($) 256.5 m	Valuation ($) 840.9 m	Valuation ($) N/A	Valuation ($) 174.4 m
Financial
Revenue (est.)	Revenue (est.) $40.5m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $11.2m (FY, 2025)
Net income	Net income ($160.1m) (FY, 2025)	Net income ($244.2m) (FY, 2025)	Net income N/A	Net income ($148.1m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 210m	Total funding raised $ 700m	Total funding raised $ 11.3m	Total funding raised $ 159.5m